Join
Live feed
·
INSIDERFilingvia Quantisnow
AbCellera Biologics Inc. logo

SEC Form 4: Booth Andrew bought $492,150 worth of shares (85,000 units at $5.79), increasing direct ownership by 159% to 138,500 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABCL (AbCellera Biologics Inc.) and more on Quantisnow.